Baloxavir Marboxil
Records for this ingredient, by country (identity only).
ATC J05AX25 · 12 markets · 32 records
US 6 records · 5 shown of 5
GB 4 records · 4 shown of 4
AU 4 records · 3 shown of 3
- 40 mgtabletXOFLUZA baloxavir marboxil 20 mg film-coated tablet blister pack
- 20 mgtabletXOFLUZA baloxavir marboxil 20 mg film-coated tablet blister pack
- 80 mgtabletXOFLUZA baloxavir marboxil 20 mg film-coated tablet blister pack
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
HK 4 records · 0 shown of 0
4 records · 0 manufacturers 4 registros · 0 fabricantes 4 个记录 · 0 个厂家 4 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
CN 3 records · 3 shown of 3
JP 3 records · 3 shown of 3
- 20 mgtabletゾフルーザ錠20mg
- 10 mgtabletゾフルーザ錠20mg
- 2 %powderゾフルーザ顆粒2%分包
SG 1 records · 1 shown of 1
- 40 mgtabletXofluza
ES 1 records · 1 shown of 1
- 40 mgtabletXofluza
TW 1 records · 1 shown of 1
- 20 mgtabletXofluza紓伏效膜衣錠20毫克
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | GB | CA | AU | SG | CN | ES | TW | HK | JP | EU |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 40 mg tablet | Xofluza | Xofluza | Xofluza | XOFLUZA baloxavir marboxil 20 mg film-coated tablet blister pack | Xofluza | 速福达玛巴洛沙韦 | Xofluza | ||||
| 20 mg tablet | Xofluza | Xofluza | XOFLUZA baloxavir marboxil 20 mg film-coated tablet blister pack | 速福达玛巴洛沙韦 | Xofluza 紓伏效膜衣錠20毫克 | ゾフルーザ錠20mg | |||||
| 80 mg tablet | Xofluza | Xofluza | Xofluza | XOFLUZA baloxavir marboxil 20 mg film-coated tablet blister pack | |||||||
| 40 mg powder | Xofluza | Manufacturer: Roche Pharma(Schweiz) AG | |||||||||
| 10 mg tablet | ゾフルーザ錠20mg | ||||||||||
| 2 mg per mL / per unit basis not stated cannot compare liquid | Xofluza 2mg/ml oral suspension | ||||||||||
| 40 mg/20 mL powder | Xofluza | ||||||||||
| 30 mg powder | Xofluza | ||||||||||
| 2 % powder | ゾフルーザ顆粒2%分包 | ||||||||||
unknown | Xofluza | Xofluza | Xofluza |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
2 more strength/form rows are recorded only in JP and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en JP que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 JP 有记录（未在本表显示）。 另有 2 個規格/劑型僅在 JP 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.